173 related articles for article (PubMed ID: 31118427)
1. CD271 is a molecular switch with divergent roles in melanoma and melanocyte development.
Filipp FV; Li C; Boiko AD
Sci Rep; 2019 May; 9(1):7696. PubMed ID: 31118427
[TBL] [Abstract][Full Text] [Related]
2. Specific Activation of the CD271 Intracellular Domain in Combination with Chemotherapy or Targeted Therapy Inhibits Melanoma Progression.
Saltari A; Dzung A; Quadri M; Tiso N; Facchinello N; Hernández-Barranco A; Garcia-Silva S; Nogués L; Stoffel CI; Cheng PF; Turko P; Eichhoff OM; Truzzi F; Marconi A; Pincelli C; Peinado H; Dummer R; Levesque MP
Cancer Res; 2021 Dec; 81(23):6044-6057. PubMed ID: 34645608
[TBL] [Abstract][Full Text] [Related]
3. CD271 Expression on Patient Melanoma Cells Is Unstable and Unlinked to Tumorigenicity.
Boyle SE; Fedele CG; Corbin V; Wybacz E; Szeto P; Lewin J; Young RJ; Wong A; Fuller R; Spillane J; Speakman D; Donahoe S; Pohl M; Gyorki D; Henderson MA; Johnstone RW; Papenfuss AT; Shackleton M
Cancer Res; 2016 Jul; 76(13):3965-77. PubMed ID: 27325642
[TBL] [Abstract][Full Text] [Related]
4. CD271 determines migratory properties of melanoma cells.
Radke J; Roßner F; Redmer T
Sci Rep; 2017 Aug; 7(1):9834. PubMed ID: 28852061
[TBL] [Abstract][Full Text] [Related]
5. low neurotrophin receptor CD271 regulates phenotype switching in melanoma.
Restivo G; Diener J; Cheng PF; Kiowski G; Bonalli M; Biedermann T; Reichmann E; Levesque MP; Dummer R; Sommer L
Nat Commun; 2017 Dec; 8(1):1988. PubMed ID: 29215016
[TBL] [Abstract][Full Text] [Related]
6. Roles of endothelin signaling in melanocyte development and melanoma.
Saldana-Caboverde A; Kos L
Pigment Cell Melanoma Res; 2010 Apr; 23(2):160-70. PubMed ID: 20128875
[TBL] [Abstract][Full Text] [Related]
7. CD271 Down-Regulation Promotes Melanoma Progression and Invasion in Three-Dimensional Models and in Zebrafish.
Saltari A; Truzzi F; Quadri M; Lotti R; Palazzo E; Grisendi G; Tiso N; Marconi A; Pincelli C
J Invest Dermatol; 2016 Oct; 136(10):2049-2058. PubMed ID: 27328305
[TBL] [Abstract][Full Text] [Related]
8. BPTF transduces MITF-driven prosurvival signals in melanoma cells.
Dar AA; Majid S; Bezrookove V; Phan B; Ursu S; Nosrati M; De Semir D; Sagebiel RW; Miller JR; Debs R; Cleaver JE; Kashani-Sabet M
Proc Natl Acad Sci U S A; 2016 May; 113(22):6254-8. PubMed ID: 27185926
[TBL] [Abstract][Full Text] [Related]
9. Loss of expression of protein kinase C beta is a common phenomenon in human malignant melanoma: a result of transformation or differentiation?
Gilhooly EM; Morse-Gaudio M; Bianchi L; Reinhart L; Rose DP; Connolly JM; Reed JA; Albino AP
Melanoma Res; 2001 Aug; 11(4):355-69. PubMed ID: 11479424
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical CD271 expression correlates with melanoma progress in a case-control study.
Nielsen PS; Riber-Hansen R; Steiniche T
Pathology; 2018 Jun; 50(4):402-410. PubMed ID: 29678478
[TBL] [Abstract][Full Text] [Related]
11. Molecular biology of normal melanocytes and melanoma cells.
Bandarchi B; Jabbari CA; Vedadi A; Navab R
J Clin Pathol; 2013 Aug; 66(8):644-8. PubMed ID: 23526597
[TBL] [Abstract][Full Text] [Related]
12. Growth control of melanoma cells and melanocytes by cytokines.
Krasagakis K; Garbe C; Zouboulis CC; Orfanos CE
Recent Results Cancer Res; 1995; 139():169-82. PubMed ID: 7597288
[TBL] [Abstract][Full Text] [Related]
13. CD271
Liang L; Coudière-Morrison L; Tatari N; Stromecki M; Fresnoza A; Porter CJ; Del Bigio MR; Hawkins C; Chan JA; Ryken TC; Taylor MD; Ramaswamy V; Werbowetski-Ogilvie TE
Cancer Res; 2018 Aug; 78(16):4745-4759. PubMed ID: 29930101
[TBL] [Abstract][Full Text] [Related]
14. CD271 promotes proliferation and migration in bladder cancer.
Myoen S; Mochizuki M; Shibuya-Takahashi R; Fujimori H; Shindo N; Yamaguchi K; Yasuda J; Abe J; Imai T; Sato I; Adachi H; Kawamura S; Ito A; Tamai K
Genes Cells; 2024 Jan; 29(1):73-85. PubMed ID: 38016691
[TBL] [Abstract][Full Text] [Related]
15. The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation.
Maurus K; Hufnagel A; Geiger F; Graf S; Berking C; Heinemann A; Paschen A; Kneitz S; Stigloher C; Geissinger E; Otto C; Bosserhoff A; Schartl M; Meierjohann S
Oncogene; 2017 Sep; 36(36):5110-5121. PubMed ID: 28481878
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells.
Buscà R; Berra E; Gaggioli C; Khaled M; Bille K; Marchetti B; Thyss R; Fitsialos G; Larribère L; Bertolotto C; Virolle T; Barbry P; Pouysségur J; Ponzio G; Ballotti R
J Cell Biol; 2005 Jul; 170(1):49-59. PubMed ID: 15983061
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-Inducible Factor-1α and CD271 inversely correlate with melanoma invasiveness.
Marconi A; Borroni RG; Truzzi F; Longo C; Pistoni F; Pellacani G; Pincelli C
Exp Dermatol; 2015 May; 24(5):396-8. PubMed ID: 25739328
[TBL] [Abstract][Full Text] [Related]
18. Functional expression of olfactory receptors in human primary melanoma and melanoma metastasis.
Gelis L; Jovancevic N; Bechara FG; Neuhaus EM; Hatt H
Exp Dermatol; 2017 Jul; 26(7):569-576. PubMed ID: 28191688
[TBL] [Abstract][Full Text] [Related]
19. Molecular regulation of melanocyte senescence.
Bennett DC; Medrano EE
Pigment Cell Res; 2002 Aug; 15(4):242-50. PubMed ID: 12100489
[TBL] [Abstract][Full Text] [Related]
20. p16/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: possible implications for melanoma progression.
Sviderskaya EV; Gray-Schopfer VC; Hill SP; Smit NP; Evans-Whipp TJ; Bond J; Hill L; Bataille V; Peters G; Kipling D; Wynford-Thomas D; Bennett DC
J Natl Cancer Inst; 2003 May; 95(10):723-32. PubMed ID: 12759390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
